Journal of Virology, December 1998, p. 9729-9737, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Institute of Biomedical Sciences,
Received 7 April 1998/Accepted 9 September 1998
Here we report that severe combined immunodeficient (SCID) mice
engrafted with human K562 cells (K562-SCID mice) can be used as an
animal model to study dengue virus (DEN) infection. After intratumor
injection into K562 cell masses of PL046, a Taiwanese DEN-2 human
isolate, the K562-SCID mice showed neurological signs of paralysis and
died at approximately 2 weeks postinfection. In addition to being
detected in the tumor masses, high virus titers were detected in the
peripheral blood and the brain tissues, indicating that DEN had
replicated in the infected K562-SCID mice. In contrast, the SCID mice
were resistant to DEN infection and the mock-infected K562-SCID mice
survived for over 3 months. These data illustrate that DEN infection
contributed directly to the deaths of the infected K562-SCID mice.
Other serotypes of DEN were also used to infect the K562-SCID mice, and
the mortality rates of the infected mice varied with different
challenge strains, suggesting the existence of diverse degrees of
virulence among DENs. To determine whether a neutralizing antibody
against DEN in vitro was also protective in vivo, the K562-SCID mice
were challenged with DEN-2 and received antibody administration at the
same time or 1 day earlier. Our results revealed that the antibody-treated mice exhibited a reduction in mortality and a delay of
paralysis onset after DEN infection. In contrast to K562-SCID, the
persistently DEN-infected K562 cells generated in vitro invariably failed to be implanted in the mice. It seems that in the early stage of
implantation, a gamma interferon activated, nitric oxide-mediated anti-DEN effect might play a role in the innate immunity against DEN-infected cells. The system described herein offers an opportunity to explore DEN replication in vivo and to test various antiviral protocols in infected hosts.
*
Corresponding author. Mailing address: Institute of
Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan, Republic of China. Phone: (886)-2-2652-3902. Fax: (886)-2-2782-9224. E-mail: yll{at}ibms.sinica.edu.tw.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|